Denosumab for Tumor-Induced Hypercalcemia Complicated by Renal Failure.

The article presents a case study of a 50-year-old woman with a history of chronic pulmonary disease presented with fatigue, nausea, and generalized bone pain who was administered with a human monoclonal antibody denosumab. It provides information that the efficacy of denosumab was determined for the treatment of severe tumor-induced hypercalcemia. It concludes that denosumab is a safe alternative for the treatment of tumor-induced hypercalcemia complicated by renal failure.